Moon‐Hong Kim

1.2k total citations
30 papers, 841 citations indexed

About

Moon‐Hong Kim is a scholar working on Obstetrics and Gynecology, Reproductive Medicine and Surgery. According to data from OpenAlex, Moon‐Hong Kim has authored 30 papers receiving a total of 841 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Obstetrics and Gynecology, 11 papers in Reproductive Medicine and 8 papers in Surgery. Recurrent topics in Moon‐Hong Kim's work include Endometrial and Cervical Cancer Treatments (17 papers), Ovarian cancer diagnosis and treatment (9 papers) and Cervical Cancer and HPV Research (5 papers). Moon‐Hong Kim is often cited by papers focused on Endometrial and Cervical Cancer Treatments (17 papers), Ovarian cancer diagnosis and treatment (9 papers) and Cervical Cancer and HPV Research (5 papers). Moon‐Hong Kim collaborates with scholars based in South Korea, Japan and China. Moon‐Hong Kim's co-authors include Sang‐Young Ryu, Sang-Il Park, Kyunghee Lee, Chul-Koo Cho, Kidong Kim, Yong Sang Song, Jae‐Weon Kim, Soon‐Beom Kang, Byung‐Ho Nam and Hyo‐Pyo Lee and has published in prestigious journals such as PLoS ONE, British Journal of Cancer and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Moon‐Hong Kim

27 papers receiving 818 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Moon‐Hong Kim South Korea 17 505 274 263 210 167 30 841
Alexandre André Balieiro Anastácio da Costa Brazil 18 246 0.5× 276 1.0× 116 0.4× 174 0.8× 301 1.8× 64 832
Alejandro Rojo‐Sebastián Spain 14 200 0.4× 142 0.5× 89 0.3× 75 0.4× 122 0.7× 18 686
Yalan Bi China 16 148 0.3× 134 0.5× 89 0.3× 134 0.6× 221 1.3× 51 718
Christine Gennigens Belgium 13 153 0.3× 95 0.3× 68 0.3× 77 0.4× 171 1.0× 55 530
Sally Baron‐Hay Australia 14 148 0.3× 220 0.8× 87 0.3× 82 0.4× 388 2.3× 48 775
Małgorzata Fuksiewicz Poland 14 79 0.2× 68 0.2× 88 0.3× 76 0.4× 321 1.9× 42 620
Toshiko Minamoto Japan 13 162 0.3× 130 0.5× 51 0.2× 68 0.3× 262 1.6× 34 538
S. Goodrich United States 9 253 0.5× 511 1.9× 19 0.1× 163 0.8× 142 0.9× 14 737
P. Athanassiades Greece 12 63 0.1× 61 0.2× 60 0.2× 85 0.4× 139 0.8× 47 470
Haitham Arabi United States 12 152 0.3× 151 0.6× 44 0.2× 62 0.3× 67 0.4× 29 450

Countries citing papers authored by Moon‐Hong Kim

Since Specialization
Citations

This map shows the geographic impact of Moon‐Hong Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Moon‐Hong Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Moon‐Hong Kim more than expected).

Fields of papers citing papers by Moon‐Hong Kim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Moon‐Hong Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Moon‐Hong Kim. The network helps show where Moon‐Hong Kim may publish in the future.

Co-authorship network of co-authors of Moon‐Hong Kim

This figure shows the co-authorship network connecting the top 25 collaborators of Moon‐Hong Kim. A scholar is included among the top collaborators of Moon‐Hong Kim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Moon‐Hong Kim. Moon‐Hong Kim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Kim, Heyjin, et al.. (2024). Therapy-related myeloid neoplasms in Korean patients with ovarian or primary peritoneal cancer treated with poly(ADP-ribose) polymerase inhibitors. Translational Cancer Research. 13(11). 6018–6027. 1 indexed citations
4.
Lee, Jina, Hee Jung Jung, Sang‐Young Ryu, et al.. (2020). An extremely rare elderly case of proximal epithelioid sarcoma of the vulva: case report with a review of literatures. Obstetrics & Gynecology Science. 63(5). 670–674. 4 indexed citations
5.
Kim, Moon‐Hong, et al.. (2020). Self‐obtained vaginal samples for HPV DNA testing to detect HPV‐related cervical disease. International Journal of Gynecology & Obstetrics. 154(1). 127–132. 4 indexed citations
7.
Kim, Tae Hun, et al.. (2017). Prognostic Importance of the Site of Recurrence in Patients With Metastatic Recurrent Cervical Cancer. International Journal of Radiation Oncology*Biology*Physics. 98(5). 1124–1131. 50 indexed citations
8.
Kim, Moon‐Hong, Moon-Sun Kim, Wonwoo Kim, et al.. (2015). Suppressor of Cytokine Signaling (SOCS) Genes Are Silenced by DNA Hypermethylation and Histone Deacetylation and Regulate Response to Radiotherapy in Cervical Cancer Cells. PLoS ONE. 10(4). e0123133–e0123133. 50 indexed citations
9.
Kim, Mi‐Sook, et al.. (2014). Salvage stereotactic body radiotherapy for locally recurrent uterine cervix cancer at the pelvic sidewall: Feasibility and complication. Asia-Pacific Journal of Clinical Oncology. 12(2). e280–e288. 28 indexed citations
10.
Kim, Moon‐Hong, Byung‐Ho Nam, Eunwoo Song, et al.. (2013). Intermediate-risk grouping of cervical cancer patients treated with radical hysterectomy: a Korean Gynecologic Oncology Group study. British Journal of Cancer. 110(2). 278–285. 74 indexed citations
11.
Park, Sang-Il, et al.. (2012). Clinicopathologic factors for central recurrence in patients with locally advanced bulky cervical cancer. European Journal of Obstetrics & Gynecology and Reproductive Biology. 161(2). 219–223. 8 indexed citations
12.
Kim, Moon‐Hong, et al.. (2012). Characteristics of thyroid incidentalomas detected by pre-treatment [18F]FDG PET or PET/CT in patients with cervical cancer. Journal of Gynecologic Oncology. 23(1). 43–43. 9 indexed citations
13.
Kim, Kidong, et al.. (2011). Discharge criteria should be validated in patients who undergo ambulatory gynecologic surgery. Journal of Gynecologic Oncology. 22(2). 140–140.
14.
Ryu, Sang‐Young, Kidong Kim, Sang-Il Park, et al.. (2011). Randomized Clinical Trial of Weekly vs. Triweekly Cisplatin-Based Chemotherapy Concurrent With Radiotherapy in the Treatment of Locally Advanced Cervical Cancer. International Journal of Radiation Oncology*Biology*Physics. 81(4). e577–e581. 54 indexed citations
15.
Ryu, Sang‐Young, Sang-Il Park, Byung‐Ho Nam, et al.. (2010). Is Adjuvant Chemoradiotherapy Overtreatment in Cervical Cancer Patients With Intermediate Risk Factors?. International Journal of Radiation Oncology*Biology*Physics. 79(3). 794–799. 53 indexed citations
16.
17.
Kang, Sokbom, Yong Beom Kim, Moon‐Hong Kim, et al.. (2004). Polymorphism in the nuclear factor kappa-B binding promoter region of cyclooxygenase-2 is associated with an increased risk of bladder cancer. Cancer Letters. 217(1). 11–16. 51 indexed citations
18.
Kim, Moon‐Hong, Yong Sang Song, Daehee Kang, et al.. (2003). Expression of cyclooxygenase-1 and -2 associated with expression of VEGF in primary cervical cancer and at metastatic lymph nodes. Gynecologic Oncology. 90(1). 83–90. 58 indexed citations
19.
Ryu, Sang‐Young, et al.. (2003). Detection of early recurrence with 18F-FDG PET in patients with cervical cancer.. PubMed. 44(3). 347–52. 109 indexed citations
20.
Roh, Ju‐Won, Moon‐Hong Kim, Jae‐Weon Kim, et al.. (2001). Polymorphisms in codon 31 of p21 and cervical cancer susceptibility in Korean women. Cancer Letters. 165(1). 59–62. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026